Ser309
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser309  -  TFCP2 (human)

Site Information
SLGEGNGsPNHQPEP   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 7965105

In vivo Characterization
Methods used to characterize site in vivo:
immunoprecipitation ( 1 ) , microscopy-colocalization with upstream kinase ( 2 ) , mutation of modification site ( 1 , 2 ) , phospho-antibody ( 2 ) , western blotting ( 2 )
Relevant cell line - cell type - tissue:

Upstream Regulation
Regulatory protein:
CCNC (human) ( 2 ) , p21Cip1 (human) ( 2 ) , p27Kip1 (human) ( 2 ) , PIN1 (human) ( 1 )
Putative in vivo kinases:
CDK2 (human) ( 2 ) , CDK3 (human) ( 2 )
Kinases, in vitro:
CDK2 (human) ( 2 ) , CDK3 (human) ( 2 )
Treatments:
EGF ( 2 ) , serum_starvation ( 2 ) , U0126 ( 2 )

Downstream Regulation
Effects of modification on TFCP2:
activity, inhibited ( 1 , 2 )
Effects of modification on biological processes:
cell cycle regulation ( 2 ) , transcription, inhibited ( 1 , 2 )

References 

1

Saxena UH, et al. (2010) Prolyl isomerase Pin1 regulates transcription factor LSF (TFCP2) by facilitating dephosphorylation at two serine-proline motifs. J Biol Chem 285, 31139-47
20682773   Curated Info

2

Saxena UH, et al. (2009) Phosphorylation by cyclin C/cyclin-dependent kinase 2 following mitogenic stimulation of murine fibroblasts inhibits transcriptional activity of LSF during G1 progression. Mol Cell Biol 29, 2335-45
19237534   Curated Info